Coronavirus vaccine

COVID Vaccine Booster: Now, INSACOG Says More Experiments Needed To Assess Impact

New Delhi: In what can be construed by the public as confusing signals, India’s top genome sequencing laboratories have now said that many more scientific experiments are required to assess the impact of COVID-19 vaccine booster dose.

In its bulletin dated November 29, the Indian SARS-CoV-2 Consortium on Genomics (INSACOG) had recommended that a booster dose may be considered for those aged 40 and above, with priority to the most high-risk/high-exposure section of population.

But in the bulletin issued on Saturday, INSACOG said the mention of booster dose in its previous bulletin was merely a “discussion about the potential role of additional dose of COVID-19 vaccines in high-risk populations”.

“Many more scientific experiments are needed to assess the impacts of booster dose, which are being guided and monitored by National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC),” the INSACOG said on December 4.

INSACOG also clarified that recommendations and suggestions regarding vaccines, schedule and roll-out came under the expressed mandate of NTAGI and NEGVAC.

Union Health minister Mansukh Mandaviya said in the Lok Sabha on Friday that the focus of vaccination drive would be on the second dose, and that a decision on booster dose and vaccine for kids will be taken on the basis of scientific advice.

OB Bureau

Leave a Comment

Recent Posts

Narasingha Mishra Heads Odisha Cong Committee For Panchayat & Civic Body Polls

Bhubaneswar: The Congress party on Monday constituted an election management  committee for the upcoming urban… Read More

4 hours ago

Daily COVID Caseload: 3 Places In Bhubaneswar Report Over 100 New Cases

Bhubaneswar: The daily COVID caseload continued to rise in the capital city as 3 places… Read More

5 hours ago

Govt Urged To Reduce Gap Between Booster Dose From 9 To 6 Months

Hyderabad: After Prime Minister Narendra Modi announced last month that a ‘precaution’ dose of the… Read More

5 hours ago

Odisha Cong Forms 7-Member Committee To Probe Disturbance At JSW Project Site

Bhubaneswar: The Congress party on Monday constituted a fact finding committee to inquire into disturbances… Read More

5 hours ago

Land Acquisition Work For JSW Project Resumes In Odisha’s Jagatsinghpur

Jagatsinghpur: Three days after violent clashes between villagers and police at Dhinkia, the site of… Read More

6 hours ago

India’s First mRNA Vaccine May Be Effective Against Omicron; Trials To Begin Soon

New Delhi: Human trials for India’s first mRNA (messenger RNA) vaccine will begin next month… Read More

6 hours ago